Pharm Exec15h
FDA Approves Azurity Pharmaceuticals’ Myhibbin as an Oral Suspension for Organ Transplant Recipients
Myhibbin is reportedly the first FDA-approved liquid formulation of mycophenolate, a key immunosuppressant used to prevent ...
Pharm Exec17h
FDA Accepts Bristol Myers Squibb’s Biologics License Application for Opdivo’s Subcutaneous Formulation Across All Previous Indications
Acceptance of the application was based on promising results from the Phase III CheckMate -67T study, which displayed ...
Pharm Exec22h
NJ Doctor Becomes First In State to Use PathKeeper Surgical Navigation System on Patient
Dr. Jonathan Lewin is the first surgeon in the state of New Jersey to use the PathKeeper Surgical Spinal Navigation System on ...
Pharm Exec22h
Premera Blue Cross Names Dr. Romilla Batra as Chief Medical Officer
Premera Blue Cross announced that it has appointed Dr. Romilla Batra as senior vice president and chief medical officer. 1 In ...